UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bedaquiline: a review of human pharmacokinetics and drug-drug interactions

Journal of antimicrobial chemotherapy, 2014-09, Vol.69 (9), p.2310-2318

2014

Volltextzugriff (PDF)

Addressing bedaquiline treatment interruptions in the treatment of drug-resistant TB

The international journal of tuberculosis and lung disease, 2022-07, Vol.26 (7), p.671-677

2022

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of the Non-Nucleoside Reverse-Transcriptase Inhibitor Etravirine in Treatment-Experienced HIV-1-Infected Patients

Clinical pharmacology and therapeutics, 2010-11, Vol.88 (5), p.695-703

2010

Volltextzugriff (PDF)

Efficacy of Cerebrospinal Fluid (CSF)–Penetrating Antiretroviral Drugs against HIV in the Neurological Compartment: Different Patterns of Phenotypic Resistance in CSF and Plasma

Clinical infectious diseases, 2005-12, Vol.41 (12), p.1787-1793

2005

Volltextzugriff (PDF)

Antiretroviral drugs and the central nervous system

AIDS (London), 1998-10, Vol.12 (15), p.1941-1955

1998

Volltextzugriff (PDF)

Assessment of the steady‐state pharmacokinetic interaction between etravirine administered as two different formulations and tenofovir disoproxil fumarate in healthy volunteers

HIV medicine, 2009-03, Vol.10 (3), p.173-181

2009

Volltextzugriff (PDF)

Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience

Antiviral therapy, 2001-12, Vol.6 (4), p.201-229

2001

Volltextzugriff (PDF)

Ritonavir Enables Combined Therapy with Rifampin and Saquinavir

Clinical infectious diseases, 1999-12, Vol.29 (6), p.1586-1586

1999

Volltextzugriff (PDF)

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

The Lancet (British edition), 1998-05, Vol.351 (9115), p.1547-1551

1998

Volltextzugriff (PDF)

Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management : recommendations for the European setting

AIDS (London), 2001-02, Vol.15 (3), p.309-320

2001

Volltextzugriff (PDF)

Bcl-2 and Bax proteins are present in interphase nuclei of mammalian cells

Cell death and differentiation, 2000-04, Vol.7 (4), p.384-392

2000

Volltextzugriff (PDF)

Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir

AIDS (London), 2000-06, Vol.14 (9), p.1187-1194

2000

Volltextzugriff (PDF)

Effect of Repeated Doses of Darunavir plus Low-Dose Ritonavir on the Pharmacokinetics of Sildenafil in Healthy Male Subjects: Phase I Randomized, Open-Label, Two-Way Crossover Study

Clinical drug investigation, 2008, Vol.28 (8), p.479-485

2008

Volltextzugriff (PDF)

The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals

AIDS (London), 1999-10, Vol.13 (14), p.F95-F99

1999

Volltextzugriff (PDF)

Nuclear partners of Bcl-2: Bax and PML

DNA and cell biology, 2004-06, Vol.23 (6), p.351-354

Hoetelmans, R W M

2004

Volltextzugriff (PDF)

The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy

AIDS (London), 1998-07, Vol.12 (11), p.F111-F115

1998

Volltextzugriff (PDF)

Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine

AIDS (London), 2000-07, Vol.14 (11), p.1583-1589

2000

Volltextzugriff (PDF)

The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV‐1‐infected individuals

British journal of clinical pharmacology, 2001-06, Vol.51 (6), p.631-635

2001

Volltextzugriff (PDF)

Pharmacokinetic evaluation of the interaction between etravirine and rifabutin or clarithromycin in HIV-negative, healthy volunteers: results from two Phase 1 studies

Journal of antimicrobial chemotherapy, 2014-03, Vol.69 (3), p.728-734

2014

Volltextzugriff (PDF)

Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy

AIDS (London), 1998-07, Vol.12 (11), p.F117-F122

1998

Volltextzugriff (PDF)

Pharmacokinetics of the Protease Inhibitor Indinavir in Human Immunodeficiency Virus Type 1-Infected Children

Antimicrobial Agents and Chemotherapy, 2001-03, Vol.45 (3), p.701-705

2001

Volltextzugriff (PDF)

Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals : a pharmacokinetic pilot study

AIDS (London), 2000-06, Vol.14 (9), p.F103-F110

2000

Volltextzugriff (PDF)

Pharmacological exposure and the development of drug resistance in HIV

Antiviral therapy, 2001-01, Vol.6 (2_suppl), p.37-47

HOETELMANS, Richard

2001

Volltextzugriff (PDF)

Deep salvage with amprenavir and lopinavir/ritonavir: correlation of pharmacokinetics and drug resistance with pharmacodynamics

Journal of acquired immune deficiency syndromes (1999), 2004-04, Vol.35 (4), p.359-366

2004

Volltextzugriff (PDF)

Pharmacokinetic Profiles of Nevirapine and Indinavir in Various Fractions of Seminal Plasma

Antimicrobial Agents and Chemotherapy, 2001-10, Vol.45 (10), p.2902-2907

2001

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(93)

Publikationsform

Artikel
(112)

Sprache

Englisch
(112)

Erscheinungsjahr

n.n

Thema

Humans
(95)
Life Sciences & Biomedicine
(90)
Science & Technology
(90)
Biological And Medical Sciences
(65)
Medical Sciences
(65)
Pharmacology. Drug Treatments
(62)
Hiv Infections - Drug Therapy
(54)
Infectious Diseases
(53)
Aids/hiv
(49)
Male
(49)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(48)
Antiviral Agents
(47)
Adult
(45)
Virology
(39)
Immunology
(35)
Female
(33)
Middle Aged
(32)
Drug Therapy, Combination
(31)
Pharmacology & Pharmacy
(31)
Anti-Hiv Agents - Pharmacokinetics
(26)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bedaquiline: a review of human pharmacokinetics and drug-drug interactions

Addressing bedaquiline treatment interruptions in the treatment of drug-resistant TB

Pharmacokinetics and Pharmacodynamics of the Non-Nucleoside Reverse-Transcriptase Inhibitor Etravirine in Treatment-Experienced HIV-1-Infected Patients

Efficacy of Cerebrospinal Fluid (CSF)–Penetrating Antiretroviral Drugs against HIV in the Neurological Compartment: Different Patterns of Phenotypic Resistance in CSF and Plasma

Antiretroviral drugs and the central nervous system

Assessment of the steady‐state pharmacokinetic interaction between etravirine administered as two different formulations and tenofovir disoproxil fumarate in healthy volunteers

Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience

Ritonavir Enables Combined Therapy with Rifampin and Saquinavir

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management : recommendations for the European setting

Bcl-2 and Bax proteins are present in interphase nuclei of mammalian cells

Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir

Effect of Repeated Doses of Darunavir plus Low-Dose Ritonavir on the Pharmacokinetics of Sildenafil in Healthy Male Subjects: Phase I Randomized, Open-Label, Two-Way Crossover Study

The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals

Nuclear partners of Bcl-2: Bax and PML

The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy

Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine

The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV‐1‐infected individuals

Pharmacokinetic evaluation of the interaction between etravirine and rifabutin or clarithromycin in HIV-negative, healthy volunteers: results from two Phase 1 studies

Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy

Pharmacokinetics of the Protease Inhibitor Indinavir in Human Immunodeficiency Virus Type 1-Infected Children

Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals : a pharmacokinetic pilot study

Pharmacological exposure and the development of drug resistance in HIV

Deep salvage with amprenavir and lopinavir/ritonavir: correlation of pharmacokinetics and drug resistance with pharmacodynamics

Pharmacokinetic Profiles of Nevirapine and Indinavir in Various Fractions of Seminal Plasma

Suchergebnisse filtern